IL62424A - Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them - Google Patents

Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL62424A
IL62424A IL62424A IL6242481A IL62424A IL 62424 A IL62424 A IL 62424A IL 62424 A IL62424 A IL 62424A IL 6242481 A IL6242481 A IL 6242481A IL 62424 A IL62424 A IL 62424A
Authority
IL
Israel
Prior art keywords
depolymerisation
mucopolysaccharide
heparin
preparation
pharmaceutical compositions
Prior art date
Application number
IL62424A
Other languages
English (en)
Other versions
IL62424A0 (en
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9239907&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL62424(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Publication of IL62424A0 publication Critical patent/IL62424A0/xx
Publication of IL62424A publication Critical patent/IL62424A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL62424A 1980-03-20 1981-03-18 Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them IL62424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8006282A FR2478646A2 (fr) 1980-03-20 1980-03-20 Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir

Publications (2)

Publication Number Publication Date
IL62424A0 IL62424A0 (en) 1981-05-20
IL62424A true IL62424A (en) 1984-12-31

Family

ID=9239907

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62424A IL62424A (en) 1980-03-20 1981-03-18 Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4686288A (xx)
EP (1) EP0037319B2 (xx)
JP (1) JPH0231081B2 (xx)
AR (1) AR227417A1 (xx)
AT (1) ATE26450T1 (xx)
CA (1) CA1207759A (xx)
CS (1) CS222245B2 (xx)
DD (1) DD157561A5 (xx)
DE (1) DE3176086D1 (xx)
DK (1) DK172877B1 (xx)
ES (1) ES501130A0 (xx)
FR (1) FR2478646A2 (xx)
HU (1) HU188657B (xx)
IE (1) IE52951B1 (xx)
IL (1) IL62424A (xx)
PL (1) PL135948B1 (xx)
SU (1) SU1658820A3 (xx)
UA (1) UA5934A1 (xx)
WO (1) WO1981002737A1 (xx)
YU (1) YU43008B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2553287B1 (fr) * 1983-10-18 1986-09-12 Choay Sa Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
CA1260461A (fr) * 1984-10-18 1989-09-26 Jean-Claude Lormeau Procede de preparation de compositions de mucopolysaccharides dotes d'une activite antithrombotique elevee
FR2572080B1 (fr) * 1984-10-18 1987-06-26 Dropic Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
IT1230582B (it) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
JP2871822B2 (ja) * 1989-08-29 1999-03-17 玉造株式会社 末端に２，５―アンヒドロマンニトール基または２，５―アンヒドロマンノース基を有するキチン・キトサンオリゴマーおよびその製造方法
WO1991015216A1 (en) * 1990-04-05 1991-10-17 Kennedy Thomas P Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
DE4217917A1 (de) * 1992-05-30 1993-12-02 Job Prof Dr Med Harenberg Immobilisation von chemisch kovalent gebundenem Heparin an Polymere mit Arylresten im Polymer
JP3390477B2 (ja) * 1993-01-25 2003-03-24 生化学工業株式会社 薬剤組成物及びその製造法
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
DK0946185T4 (da) * 1996-11-27 2010-08-30 Aventis Pharma Inc Farmaceutisk præparat, som omfatter en forbindelse med anti-Xa-aktivitet og en blodpladeaggregations antagonistforbindelse
US5945457A (en) * 1997-10-01 1999-08-31 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science Process for preparing biologically compatible polymers and their use in medical devices
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll AG, 67061 Ludwigshafen Organprotektive Lösungen
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP2402753A1 (en) * 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US20040171819A1 (en) * 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CA2724910C (en) 2008-05-30 2015-09-01 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CN114616340A (zh) 2019-07-09 2022-06-10 奥普蒂姆维亚有限公司 合成抗凝血多糖的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
FR2440376A1 (fr) * 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
GB2071127B (en) * 1980-02-29 1984-07-25 Italfarmaco Spa Process for the purification of glucosaninoglucans
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity

Also Published As

Publication number Publication date
YU43008B (en) 1989-02-28
SU1658820A3 (ru) 1991-06-23
ES8201596A1 (es) 1982-01-16
IL62424A0 (en) 1981-05-20
DK172877B1 (da) 1999-09-06
FR2478646B2 (xx) 1983-06-24
HU188657B (en) 1986-05-28
DD157561A5 (de) 1982-11-17
ES501130A0 (es) 1982-01-16
EP0037319B1 (fr) 1987-04-08
CA1207759A (en) 1986-07-15
IE52951B1 (en) 1988-04-27
FR2478646A2 (fr) 1981-09-25
US4686288A (en) 1987-08-11
PL230237A1 (en) 1981-11-13
EP0037319A1 (fr) 1981-10-07
ATE26450T1 (de) 1987-04-15
DK511381A (da) 1981-11-18
WO1981002737A1 (fr) 1981-10-01
IE810632L (en) 1981-09-20
PL135948B1 (en) 1986-01-31
UA5934A1 (uk) 1994-12-29
DE3176086D1 (en) 1987-05-14
AR227417A1 (es) 1982-10-29
YU73681A (en) 1983-10-31
EP0037319B2 (fr) 1995-06-28
CS222245B2 (en) 1983-05-27
JPS57500335A (xx) 1982-02-25
JPH0231081B2 (xx) 1990-07-11

Similar Documents

Publication Publication Date Title
IL62424A (en) Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them
IL62866A (en) Mixtures of sulphated polysaccharides,their preparation and pharmaceutical compositions containing them
IL63940A0 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
IL61201A0 (en) Oligosaccharides, their obtention and pharmaceutical compositions containing them
IL64444A0 (en) 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them
DE3166300D1 (en) Benzopyrans, their production and pharmaceutical compositions containing them
DE3167679D1 (en) Pharmaceutical forms, their preparation and compositions containing the same
IL62622A0 (en) Tricyclic ethers,their preparation and pharmaceutical compositions containing them
IL62824A (en) Phthalyltaurine derivatives,their preparation and pharmaceutical compositions comprising them
DE3169095D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL62660A0 (en) 4,5-diaryl-alpha-(polyfluoroalkyl)-1h-pyrrole-2-methanamines,their preparation and pharmaceutical compositions containing them
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
IL63524A0 (en) Imidazoquinazoline derivatives,their manufacture and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
IL63145A (en) Imidazothienopyrimidinedione derivatives,their manufacture and pharmaceutical compositions containing them
IL70324A0 (en) Ethers,their production and pharmaceutical compositions containing them
IL63245A0 (en) 3-aminopropoxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
IL62592A0 (en) Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them
IL62606A0 (en) Pyrrolylpiperidines,their preparation and pharmaceutical compositions containing them
IL63917A0 (en) 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them
HK12384A (en) Novel veratramides,their preparation and pharmaceutical compositions containing them
IL62605A (en) 2-isoxazol-4-yl-3-aminoethyl-1h-indole derivatives,their production and pharmaceutical compositions containing them
IL63174A0 (en) Dibenzindole derivatives,their preparation and pharmaceutical compositions containing them
IL56962A (en) Substituted n-iminomethyl-piperidines,their preparation and pharmaceutical compositions containing them
IL62116A (en) Benzylidenimine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
EXP Patent expired